Subconjunctival hemorrhage (SCH) is a common condition in which bleeding occurs in the space between the conjunctiva and the sclera. This condition can be caused by a variety of factors, including trauma, sudden changes in blood pressure, and certain diseases such as hypertension and coagulopathy. SCH usually does not lead to serious consequences and has a good prognosis, but it can be alarming to patients, as it is visually very noticeable. This process can exist as single or multiple hemorrhages and is usually accompanied by pain in the eye, but in most cases it resolves without additional treatment within a few weeks. An important aspect is that this condition is often a harbinger of more serious disorders, so it requires careful examination.
History of the disease and interesting historical facts
Subconjunctival hemorrhage has been known since ancient times. The works of Hippocrates mention cases of hemorrhages in the eye, which were described as a consequence of various injuries and diseases. For centuries, doctors have collected data on the causes and consequences of this condition. In the 18th century, the first works were published describing the principles of treatment and diagnosis of SCH, noting that many cases do not require treatment. Interestingly, in the late 19th century, many studies were conducted on the pathogenesis and etiology of hemorrhages, which laid the foundation for the modern understanding of this condition. Thanks to scientific advances and the development of imaging technology such as ophthalmoscopy, it has become possible to more accurately diagnose and examine this condition.
Epidemiology
According to epidemiological studies, subconjunctival hemorrhage occurs in approximately 1-2% of the population per year, making it a fairly common occurrence. A higher risk of developing it is observed in patients with hypertension, diabetes, and other systemic diseases. The epidemiology of SCH also shows that this condition is more common in older people, who have a higher predisposition to impaired vascular permeability. In addition, studies show that cases of SCH may have clear associations with physical activity or transient conditions such as coughing and sneezing.
Genetic predisposition to this disease
To date, studies have not identified a significant genetic predisposition to subconjunctival hemorrhage. However, there are genes associated with inherited coagulopathies that may increase the risk of developing this condition. Major groups of genes involved in hemostasis and vascular tone, such as the factor V Leiden and protein S genes, may in certain circumstances lead to increased susceptibility to SCH. Studies have also identified potential mutations associated with impaired vascular response and increased vascular permeability that have undergone genetic testing.
Risk factors for the development of this disease
Risk factors for subconjunctival hemorrhage can be classified into physiological and external:
- Arterial hypertension
- Diabetic disorders
- Systemic diseases such as vasculitis
- Intense physical activity leading to increased venous pressure
- Inflammatory eye diseases
- Injuries to the eyes or facial area
- Side effects of anticoagulant treatment
These factors can act either individually or in combination to increase the risk of developing subconjunctival hemorrhage.
Diagnosis of this disease
The diagnosis of subconjunctival hemorrhage is based on clinical examination and relies on the main symptoms, such as:
- Obvious hemorrhage into the conjunctiva
- Feeling of discomfort or pressure in the eyes
- Unstable vision with occasional pain
Laboratory tests may include a complete blood count to assess coagulation status and check for thrombocytopenia. Radiologic tests, such as an ocular ultrasound, may be necessary to rule out other pathologies. It is also important to conduct a differential diagnosis to rule out infectious processes, trauma, or tumors.
Treatment
In most cases, subconjunctival hemorrhage requires only observation and symptomatic therapy. The main principles of treatment include:
- Using artificial tears to reduce discomfort
- Avoidance of anticoagulant therapy if possible
- Correction of blood pressure if it is elevated
Pharmacological treatment may include the use of anti-inflammatory drugs if inflammatory components are observed. In rare cases, when the hemorrhage is accompanied by pain or visual impairment, surgery may be required to remove the blood clots.
List of medications used to treat this disease
The most commonly used drugs for the management of subconjunctival hemorrhage are:
- Artificial tears
- Nonsteroidal anti-inflammatory drugs (eg, Ibuprofen)
- Medicines for the correction of arterial hypertension
Disease monitoring
Subconjunctival hemorrhage management involves regular eye examinations and assessment of changes. The prognosis for patients is usually good, as most cases resolve on their own. However, it is important to monitor for potential complications, such as recurrent hemorrhage or decreased visual acuity. If the condition does not improve, a repeat examination is necessary to rule out more serious pathologies.
Age-related features of the disease
Subconjunctival hemorrhage is more common in older people, associated with possible systemic diseases and changes in the vascular wall. In younger age groups, including children, SCH may occur as a result of trauma or intense physical activity, but in general has a lower predisposition. In older people, it is important to identify underlying diseases such as hypertension and diabetes, which can contribute to the occurrence of subconjunctival hemorrhage.
Questions and Answers
- What is subconjunctival hemorrhage?
Subconjunctival hemorrhage is bleeding between the conjunctiva and sclera that can occur due to a variety of factors, including trauma and pressure changes. - Should subconjunctival hemorrhage be treated?
In most cases, no treatment is required as the condition resolves on its own, but symptomatic treatment can help reduce discomfort. - What are the causes of SCC?
Causes may include trauma, high blood pressure, blood disorders, and systemic diseases. - How is subconjunctival hemorrhage diagnosed?
Diagnosis is based on clinical examination and may also include laboratory tests to assess blood levels. - What is the prognosis for subconjunctival hemorrhage?
The prognosis is usually good, with most cases resolving without complications within a few weeks.
